Role of Radical Prostatectomy in Clinically Non-Organ-Confined Prostate Cancer

被引：0
作者：
Christian Gratzke
Jutta Engel
Christian G. Stief
机构：
[1] Ludwig-Maximilians-University Munich,Department of Urology
[2] Munich Cancer Registry,undefined
来源：
Current Urology Reports | 2014年 / 15卷
关键词：
Radical prostatectomy; Prostate cancer; Metastasis; Lymph node; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In patients with lymph node-positive and metastatic prostate cancer there is currently no consensus about the best possible management. Multimodal approaches including systemic and local treatment have shown to improve survival. However, the role of radical prostatectomy (RP) is currently unclear. While treatment of the primary tumor is recommended in highly selected lymph node-positive prostate cancer patients, no prospective data exist to support resection of the primary tumor in metastatic patients as a treatment modality to improve overall survival. However, recent observational studies have suggested a survival benefit after prostate tumor cytoreduction. This article reviews existing evidence on the role of RP in lymph node-positive and metastatic prostate cancer patients.
引用
收藏
相关论文
共 83 条
  • [1] Heidenreich A(2014)EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 467-79
  • [2] Bastian PJ(1995)Survival and quality of life of patients with stage d1 (t1-3 pn1-2 m0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone Eur Urol 27 202-6
  • [3] Bellmunt J(2013)Management of lymph node-positive prostate cancer: the role of surgery and radiation therapy Oncology (Williston Park, NY) 27 647-55
  • [4] Bolla M(2010)Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer Eur Urol 57 754-61
  • [5] Joniau S(2011)Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study BJU Int 107 1755-61
  • [6] van der Kwast T(2007)Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era J Urol 178 864-70
  • [7] Frohmuller HG(2003)Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 849-54
  • [8] Theiss M(2011)Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pt2-4 pn+ prostate cancer: results of a matched analysis Eur Urol 59 832-40
  • [9] Manseck A(2006)Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy Lancet Oncol 7 472-9
  • [10] Wirth MP(2013)Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and gleason score BJU Int 111 1237-44
123456789